260 related articles for article (PubMed ID: 22187370)
1. Central role for interleukin-2 in type 1 diabetes.
Hulme MA; Wasserfall CH; Atkinson MA; Brusko TM
Diabetes; 2012 Jan; 61(1):14-22. PubMed ID: 22187370
[TBL] [Abstract][Full Text] [Related]
2. The crucial role of IL-2/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies.
Chistiakov DA; Voronova NV; Chistiakov PA
Immunol Lett; 2008 Jun; 118(1):1-5. PubMed ID: 18417224
[TBL] [Abstract][Full Text] [Related]
3. The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation.
Bayer AL; Pugliese A; Malek TR
Immunol Res; 2013 Dec; 57(1-3):197-209. PubMed ID: 24214027
[TBL] [Abstract][Full Text] [Related]
4. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.
Wang X; Rickert M; Garcia KC
Science; 2005 Nov; 310(5751):1159-63. PubMed ID: 16293754
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the human interleukin-2/interleukin-2 receptor system: a role for immunosuppression.
Kaempfer R
Proc Soc Exp Biol Med; 1994 Jul; 206(3):176-80. PubMed ID: 8016149
[TBL] [Abstract][Full Text] [Related]
6. The interleukin-2/interleukin-2 receptor system: structural, immunological, and clinical features.
Semenzato G; Pizzolo G; Zambello R
Int J Clin Lab Res; 1992; 22(3):133-42. PubMed ID: 1520910
[TBL] [Abstract][Full Text] [Related]
7. Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review.
Olejniczak K; Kasprzak A
Med Sci Monit; 2008 Oct; 14(10):RA179-89. PubMed ID: 18830208
[TBL] [Abstract][Full Text] [Related]
8. IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization.
Li CR; Deiro MF; Godebu E; Bradley LM
J Autoimmun; 2011 Nov; 37(3):217-27. PubMed ID: 21745722
[TBL] [Abstract][Full Text] [Related]
9. Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD.Idd3 mice.
Liu SM; Lee DH; Sullivan JM; Chung D; Jäger A; Shum BO; Sarvetnick NE; Anderson AC; Kuchroo VK
J Clin Invest; 2011 Nov; 121(11):4303-10. PubMed ID: 22019586
[TBL] [Abstract][Full Text] [Related]
10. The structure of the interleukin-15 alpha receptor and its implications for ligand binding.
Lorenzen I; Dingley AJ; Jacques Y; Grötzinger J
J Biol Chem; 2006 Mar; 281(10):6642-7. PubMed ID: 16377614
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2.
Smith KA
Curr Opin Immunol; 1992 Jun; 4(3):271-6. PubMed ID: 1418705
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction by IL-2 and its receptors as target in treatment of rheumatoid arthritis.
Kozanidou VI; Theocharis AD; Georgiadis A; Voulgari PV; Drosos AA; Karamanos NK
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Mar; 5(1):41-50. PubMed ID: 15777203
[TBL] [Abstract][Full Text] [Related]
13. Type I diabetes-associated tolerogenic properties of interleukin-2.
Chentoufi AA; Gaudreau S; Nguyen A; Sabha M; Amrani A; Elghazali G
Clin Dev Immunol; 2011; 2011():289343. PubMed ID: 21647403
[TBL] [Abstract][Full Text] [Related]
14. Biology of the interleukin-2 receptor.
Nelson BH; Willerford DM
Adv Immunol; 1998; 70():1-81. PubMed ID: 9755337
[TBL] [Abstract][Full Text] [Related]
15. Roles of cytokines in the pathogenesis and therapy of type 1 diabetes.
Rabinovitch A; Suarez-Pinzon WL
Cell Biochem Biophys; 2007; 48(2-3):159-63. PubMed ID: 17709885
[TBL] [Abstract][Full Text] [Related]
16. Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity.
Shi H; Liu C; Tan H; Li Y; Nguyen TM; Dhungana Y; Guy C; Vogel P; Neale G; Rankin S; Feng Y; Peng J; Tao W; Chi H
Immunity; 2018 Nov; 49(5):899-914.e6. PubMed ID: 30413360
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2, autotolerance, and autoimmunity.
Kroemer G; Andreu JL; Gonzalo JA; Gutierrez-Ramos JC; Martínez C
Adv Immunol; 1991; 50():147-235. PubMed ID: 1950796
[No Abstract] [Full Text] [Related]
18. Signaling domains of the interleukin 2 receptor.
Gaffen SL
Cytokine; 2001 Apr; 14(2):63-77. PubMed ID: 11356007
[TBL] [Abstract][Full Text] [Related]
19. Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and non-tyrosine residues of the gamma c chain.
Goldsmith MA; Lai SY; Xu W; Amaral MC; Kuczek ES; Parent LJ; Mills GB; Tarr KL; Longmore GD; Greene WC
J Biol Chem; 1995 Sep; 270(37):21729-37. PubMed ID: 7665592
[TBL] [Abstract][Full Text] [Related]
20. The interleukin 2 receptor.
Smith KA
Annu Rev Cell Biol; 1989; 5():397-425. PubMed ID: 2688708
[No Abstract] [Full Text] [Related]
[Next] [New Search]
